利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

10 条记录 (耗时 0.013 秒)

    TASK-ORIENTED INDUCTION CAPABILITIES FOR ICDS AND PROGRAMMERS
    4.
    发明公开
    TASK-ORIENTED INDUCTION CAPABILITIES FOR ICDS AND PROGRAMMERS 有权
    面向任务的感应技能FOR ICDS和编程

    公开(公告)号：EP1503824A2

    公开(公告)日：2005-02-09

    申请号：EP03746935.0

    申请日：2003-04-02

    申请人： Medtronic, Inc.

    发明人： KRAUSE, Paul, G. ,  OUSDIGIAN, Kevin, T. ,  ERICKSEN, James, H. ,  DEGROOT, Paul, J. ,  PADMANABHAN, Seema ,  WILLENBRING, James, E.

    IPC分类号： A61N1/39 ,  A61N1/372

    CPC分类号： A61N1/3943 ,  A61N1/37247

    摘要： The invention provides systems to prevent the delivery of anti-tachycardia pacing (ATP) following a defibrillation threshold (DFT) induction at implant. An algorithm that classifies episodes as induced or spontaneous is implemented, thereby enabling the ATP during charging feature to be operable only when spontaneous episodes are detected while temporarily suspending the ATP feature during the delivery of defibrillation shock after induction has been confirmed. Further, a user interface enables users to interact with an implantable medical device (IMD), particularly for setting a defibrillation threshold (DFT) or a 50 Hz burst from a single programmer screen. The user interface includes various functionalities to promote quick user access to parameters that govern diagnosis, therapy and other features of the IMD. A single screen enables the user to complete automatic and/or manual DFT inductions or a 50 Hz burst from a programmer interface while acquiring associated documentation from the same interface.

    TASK-ORIENTED INDUCTION CAPABILITIES FOR ICDS AND PROGRAMMERS
    5.
    发明授权
    TASK-ORIENTED INDUCTION CAPABILITIES FOR ICDS AND PROGRAMMERS 有权
    面向任务的感应技能FOR ICDS和编程

    公开(公告)号：EP1503824B1

    公开(公告)日：2006-06-14

    申请号：EP03746935.0

    申请日：2003-04-02

    申请人： MEDTRONIC, INC.

    发明人： KRAUSE, Paul, G. ,  OUSDIGIAN, Kevin, T. ,  ERICKSEN, James, H. ,  DEGROOT, Paul, J. ,  PADMANABHAN, Seema ,  WILLENBRING, James, E.

    IPC分类号： A61N1/39 ,  A61N1/372

    CPC分类号： A61N1/3943 ,  A61N1/37247

    摘要： The invention provides systems to prevent the delivery of anti-tachycardia pacing (ATP) following a defibrillation threshold (DFT) induction at implant. An algorithm that classifies episodes as induced or spontaneous is implemented, thereby enabling the ATP during charging feature to be operable only when spontaneous episodes are detected while temporarily suspending the ATP feature during the delivery of defibrillation shock after induction has been confirmed. Further, a user interface enables users to interact with an implantable medical device (IMD), particularly for setting a defibrillation threshold (DFT) or a 50 Hz burst from a single programmer screen. The user interface includes various functionalities to promote quick user access to parameters that govern diagnosis, therapy and other features of the IMD. A single screen enables the user to complete automatic and/or manual DFT inductions or a 50 Hz burst from a programmer interface while acquiring associated documentation from the same interface.

    METHOD AND APPARATUS FOR MONITORING PHYSIOLOGIC PARAMETERS IN CONJUNCTION WITH A TREATMENT REGIMEN
    6.
    发明公开
    METHOD AND APPARATUS FOR MONITORING PHYSIOLOGIC PARAMETERS IN CONJUNCTION WITH A TREATMENT REGIMEN 审中-公开
    方法与装置相关的治疗方案监测生理参数

    公开(公告)号：EP1267996A2

    公开(公告)日：2003-01-02

    申请号：EP01913294.3

    申请日：2001-03-02

    申请人： Medtronic, Inc.

    发明人： OUSDIGIAN, Kevin, T. ,  STONE, Karen, A. ,  PADMANABHAN, Vasant

    IPC分类号： A61N1/372

    CPC分类号： A61N1/37247

    摘要： A system including an implantable medical device and an associated external device, in which the implantable device is adapted to monitor a physiologic parameter and includes a telemetry system for transmitting information to and receiving information from the external device, including information regarding the measured physiological parameter and in which wherein the external device includes a telemetry system for receiving information from the implanted device and for transmitting information to the implanted device and is provided with a mechanism for receiving information indicative of occurences of significant therapeutic events and is further provided with a display system which combines information received from the implantable device related to the monitored physiologic parameter with the information of therapeutic significance and for displays the combined information in a time-scaled display in which the measured physiologic parameter is displayed along a common time scale with indications of occurences of the significant therapy related events. The implantable device may also include a mechanism for delivering a therapy; and the mechanism in the external device for receiving information indicative of occurrences of significant therapeutic events may receive information regarding changes in the therapy delivered by the implantable device. The mechanism in the external device for receiving information indicative of occurrences of significant therapeutic events may also or in addition receive information indicative of changes in the therapy delivered by a physician, e.g. changes in a drug therapy.

    REDUCING INAPPROPRIATE DELIVERY OF THERAPY FOR SUSPECTED NON-LETHAL ARRHYTHMIAS
    9.
    发明公开
    REDUCING INAPPROPRIATE DELIVERY OF THERAPY FOR SUSPECTED NON-LETHAL ARRHYTHMIAS 审中-公开
    复位疗法不当申请对疑似不是致命的心律失常

    公开(公告)号：EP1711226A1

    公开(公告)日：2006-10-18

    申请号：EP05705049.4

    申请日：2005-01-05

    申请人： MEDTRONIC, INC.

    发明人： OUSDIGIAN, Kevin, T.

    IPC分类号： A61N1/39 ,  A61B5/046 ,  A61B5/0464

    CPC分类号： A61N1/37252 ,  A61B5/0464 ,  A61B5/7264 ,  A61N1/3621 ,  A61N1/3956 ,  A61N1/3987

    摘要： An implantable medical device (IMD) identifies suspected non-lethal ventricular arrhythmia, and takes one or more actions in response to the identification to avoid or delay delivery of defibrillation or cardioversion shock. The IMD employs number of intervals to detect (NID) thresholds for detection of ventricular arrhythmias. When NID threshold is met, the IMD determines whether the ventricular rhythm is a suspected non-lethal rhythm despite satisfying a NID threshold. In some embodiments, the IMD increases the NID threshold, i.e., extends the time for detection, in response to identifying a rhythm as suspected non-lethal rhythm, and monitors subsequent ventricular beats to determine if the increased NID threshold is met before detecting a ventricular arrhythmia and delivering therapy. The IMD can determine whether a rhythm is a suspected non-lethal arrhythmia by, for example, comparing the median ventricular cycle length (VCL) to the median atrial cycle length (ACL).

    METHOD AND APPARATUS TO CONTROL DELIVERY OF HIGH-VOLTAGE AND ANTI-TACHY PACING THERAPY IN AN IMPLANTABLE MEDICAL DEVICE
    10.
    发明公开
    METHOD AND APPARATUS TO CONTROL DELIVERY OF HIGH-VOLTAGE AND ANTI-TACHY PACING THERAPY IN AN IMPLANTABLE MEDICAL DEVICE 有权
    一种用于控制高电压和antitachycardic起搏治疗应用程序在可植入医疗装置

    公开(公告)号：EP1418982A2

    公开(公告)日：2004-05-19

    申请号：EP02763358.5

    申请日：2002-07-25

    申请人： Medtronic, Inc.

    发明人： DEGROOT, Paul, J. ,  OUSDIGIAN, Kevin, T. ,  PADMANABHAN, Vasant ,  KRAUSE, Paul, G. ,  SHARMA, Vinod

    IPC分类号： A61N1/362

    CPC分类号： A61N1/3622 ,  A61N1/3688 ,  A61N1/3925 ,  A61N1/3956 ,  A61N1/3962 ,  A61N1/3987

    摘要： A system and method for delivering both anti-tachy pacing (ATP) therapy and high-voltage shock therapy in response to detection of abnormal cardiac rhythms is disclosed. The system controls the time between delivering ATP therapy and the charging of high-voltage capacitors in preparation for shock delivery based on a predetermined set of criteria. In one embodiment, the inventive system operates in an ATP during Capacitor Charging (ATP-DCC) mode wherein all, or substantially all, of the ATP therapy is delivered during charging of the high-voltage capacitors. Based on evaluation of the predetermined set of criteria, the system may switch to an additional ATP before Capacitor Charging (ATP-BCC) mode, wherein substantially all of the ATP therapy is delivered prior to charging of the high-voltage capacitor. According to one aspect of the invention, the predetermined set of criteria is based, at least in part, on the effectiveness of previously-delivered ATP therapy.